Previous close | 2.8000 |
Open | 3.0000 |
Bid | 1.5000 |
Ask | 4.2000 |
Strike | 22.50 |
Expiry date | 2024-01-19 |
Day's range | 3.0000 - 3.0000 |
Contract range | N/A |
Volume | |
Open interest | 255 |
JERSEY CITY, N.J., March 07, 2023--Organon Launches "Her Plan is Her Power," a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist
JERSEY CITY, N.J., February 16, 2023--Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2022.
For far too long, women's health issues have been underfunded, under researched and underserved. Leading up to International Women's Day on March 8, Organon (NYSE: OGN), a global women's health company, is challenging the healthcare ecosystem – along with academia, investors, policymakers, researchers, and others – to consider the consequences of continuing to treat women's health as an afterthought. For the second consecutive year, the company is also providing its employees, including over 400